1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F232974D80F632E785256C7C007B9872
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/can-pharmaceutical-diagnostic-companies-work-together-developing-and-preparing-a-diagnostic-test?opendocument
18
19opendocument
2044.222.134.250
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Alliances and Partnerships

Can Pharmaceutical & Diagnostic Companies Work Together?: Developing and Preparing A Diagnostic Test

DB Image

ID: 4350


Features:

Metrics, Graphics


Words: 7,300


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 22-page document discusses the critical factors that determine when a diagnostic company will move forward with the development of a diagnostic test, including technical feasability. It also addresses when best practice diagnostic companies approach pharmaceutical companies about strategic alliances, and how these alliances are best structured for the development of diagnostics.

Industries Profiled:
Pharmaceutical; Diagnostic; Research; Manufacturing; Biotech; Consumer Products; Medical Device


Companies Profiled:
Eli Lilly; bioMerieux; Visible Genetics; LipoScience; LabCorp; Tibotec-Virco; Cholestech; Diagnology; Bayer; Focus Technologies; Abbott Laboratories; AstraZeneca; GlaxoSmithKline; Becton Dickinson; Roche

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.